Results 121 to 130 of about 169 (169)
Some of the next articles are maybe not open access.
Southern Medical Journal, 1997
Infection with the hepatitis C virus (HCV) is a leading cause of chronic liver disease worldwide. Epidemiologic and natural history studies have helped to define the clinical impact of HCV infection, and molecular diagnostic assays have established clinical endpoints against which therapeutic regimens are currently tested.
openaire +3 more sources
Infection with the hepatitis C virus (HCV) is a leading cause of chronic liver disease worldwide. Epidemiologic and natural history studies have helped to define the clinical impact of HCV infection, and molecular diagnostic assays have established clinical endpoints against which therapeutic regimens are currently tested.
openaire +3 more sources
Management of Chronic Hepatitis C
Journal of the American Academy of Nurse Practitioners, 2001One purpose of the Clinical Practice Guideline column is to increase the awareness of the broad availability of existing guidelines and recommendations on various health topics. The hepatitis C virus (HCV) currently accounts for 20% to 40% of acute viral hepatitis, 60% to 80% of chronic hepatitis, and 20% to 30% of cirrhosis, end‐stage liver disease ...
Mary Jo Goolsby, James Blackwell
openaire +3 more sources
Treatment for chronic hepatitis C [PDF]
Current Gastroenterology Reports, 2003 Approximately four million Americans have been exposed to the hepatitis C virus (HCV) and are anti-HCV positive; almost three million are chronically infected and HCV RNA positive. Treatment for chronic hepatitis C has improved rapidly over the past 12 years from interferon monotherapy, with a sustained virologic response (SVR) rate of about 10% in the
openaire +2 more sources
THERAPY FOR CHRONIC HEPATITIS C
Gastroenterology Clinics of North America, 1994Hepatitis C is the silent epidemic of the 1970s and 1980s. Interferon alfa is currently the only effective treatment. Enthusiasm for interferon therapy must be tempered because advanced disease usually requires years or even decades to develop and does not occur in all patients.
Herbert L. Lim +2 more
openaire +3 more sources
Clinical Gastroenterology and Hepatology, 2005
The burden of chronic hepatitis C infection remains significant in the United States and worldwide. Increased knowledge regarding the natural history of acute and chronic infection and the key factors responsible for disease progression, risk for cirrhosis, and risk for hepatocellular carcinoma are critical in guiding secondary and tertiary prevention ...
Norah A. Terrault, Winnie Wong
openaire +3 more sources
The burden of chronic hepatitis C infection remains significant in the United States and worldwide. Increased knowledge regarding the natural history of acute and chronic infection and the key factors responsible for disease progression, risk for cirrhosis, and risk for hepatocellular carcinoma are critical in guiding secondary and tertiary prevention ...
Norah A. Terrault, Winnie Wong
openaire +3 more sources
Adiponectin in chronic hepatitis C
Clinical Journal of Gastroenterology, 2013White adipose tissue has been increasingly recognized as an important endocrine organ that secretes a number of biologically active adipokines. Adiponectin, one of the major adipokines, possesses anti-inflammatory and insulin-sensitizing properties, and its serum levels typically decline with increasing body weight.
Hitoshi Ikeda +3 more
openaire +3 more sources
2021
Chronic hepatitis C (C-HCV) is caused by an RNA virus, genotype 1a being the most common in the United States. The infection is transmitted by parenteral exposure to contaminated blood products, body fluids, and supplies used in procedures. It becomes chronic in 80% of the patients.
openaire +2 more sources
Chronic hepatitis C (C-HCV) is caused by an RNA virus, genotype 1a being the most common in the United States. The infection is transmitted by parenteral exposure to contaminated blood products, body fluids, and supplies used in procedures. It becomes chronic in 80% of the patients.
openaire +2 more sources
Pathology of Chronic Hepatitis B and Chronic Hepatitis C
Clinics in Liver Disease, 2010Histologic evaluation of the liver is a major component in the medical management and treatment algorithm of patients with chronic hepatitis B (HBV) and chronic hepatitis C (HCV). Liver biopsy in these patients remains the gold standard, and decisions on treatment are often predicated on the degree of damage and stage of fibrosis. This article outlines
openaire +3 more sources
Therapy for chronic hepatitis C
Journal of Physiology-Paris, 2001in Hungary, over the past 5 years more than 900 patients with chronic hepatitis C have been examined for treatment with interferon at 16 major hepatology centres, using unified diagnostic and therapeutical criteria. Authors give an account of their experiences on the clinical features of patients with chronic hepatitis C and report the results of the ...
Pár, Alajos +3 more
openaire +4 more sources
2018
Hepatitis C (HCV) is a common viral infection of the liver. It affects approximately 1.6% of the US population. Screening in the appropriate populations is essential as signs and symptoms of the disease are generally absent. In addition, there are multiple new treatments for HCV which are extremely effective and very well tolerated. In this chapter, we
Stanley Martin Cohen +1 more
openaire +2 more sources
Hepatitis C (HCV) is a common viral infection of the liver. It affects approximately 1.6% of the US population. Screening in the appropriate populations is essential as signs and symptoms of the disease are generally absent. In addition, there are multiple new treatments for HCV which are extremely effective and very well tolerated. In this chapter, we
Stanley Martin Cohen +1 more
openaire +2 more sources